Abstract
This review discusses the therapeutic interventions of the different stages of Lyme disease, including effectiveness and prognostics (where possible) and illustrates the various guidelines from Norway, Sweden, European Federation of Neurologic Societies (EFNS) and the Infectious Diseases Society of America (IDSA) and the recommendations from Uptodate, using the latest available research (2000-), guideline references and Uptodate recommendations which is the ultimate gold-standard for this research.